Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piarulli, F.
Right arrow Articles by Fedele, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piarulli, F.
Right arrow Articles by Fedele, D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:653-657, 2005
© 2005 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

Autoantibodies Against Oxidized LDLs and Atherosclerosis in Type 2 Diabetes

Francesco Piarulli, MD1, Annunziata Lapolla, MD1, Giovanni Sartore, MD1, Ciro Rossetti, MD1, Giuseppe Bax, MD1, Marianna Noale, MSC2, Nadia Minicuci, PHD2, Cristina Fiore, SB1, Lucio Marchioro, SB3, Enzo Manzato, MD1 and Domenico Fedele, MD1

1 Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
2 CNR Institute of Neuroscience, Aging Section, Padova, Italy
3 Department of Laboratory Medicine, Azienda Ospedaliera, Padova, Italy

Address correspondence and reprint requests to Francesco Piarulli, MD, Department of Medical and Surgical Sciences, University of Padova, Ospedale dei Colli, Via dei Colli 4, 35100 Padova, Italy. E-mail: francesco.piarulli{at}unipd.it

OBJECTIVE—The aim of our study was to examine, in type 2 diabetic patients, the relationship between autoantibodies against oxidatively modified LDL (oxLDL Ab) and two indexes of atherosclerosis, intimal-medial thickness of the common carotid artery (CCA-IMT), which reflects early atherosclerosis, and the ankle-brachial index (ABI), which reflects advanced atherosclerosis.

RESEARCH DESIGN AND METHODS—Thirty newly diagnosed type 2 diabetic patients, 30 type 2 diabetic patients with long duration of disease, and 56 control subjects were studied. To detect oxLDL Ab, the ImmunoLisa Anti-oxLDL Antibody ELISA was used. ABI was estimated at rest by strain-gauge plethysmography. Carotid B-mode imaging was performed on a high-resolution imaging system (ATL HDI 5000).

RESULTS—In patients with long duration of disease, IgG oxLDL Ab were significantly higher and ABI significantly lower compared with the other two groups. We found a correlation between IgG oxLDL Ab and CCA-IMT in all diabetic patients. A significant inverse correlation between IgG oxLDL Ab and ABI only in patients with long duration of disease was seen, demonstrating a close relationship between these autoantibodies and advanced atherosclerosis.

CONCLUSIONS—IgG OxLDL Ab may be markers of the advanced phase of the atherosclerotic process and the response of the immunological system to the oxLDL, which are present within atherosclerotic lesions.

Abbreviations: ABI, ankle-brachial index • CCA-IMT, intimal-medial thickness of the common carotid artery • FPG, fasting plasma glucose • oxLDL Ab, oxidatively modified LDL antibody


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. E. Hettema, H. Bootsma, and C. G. M. Kallenberg
Macrovascular disease and atherosclerosis in SSc
Rheumatology, May 1, 2008; 47(5): 578 - 583.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Lapolla, F. Piarulli, G. Sartore, A. Ceriello, E. Ragazzi, R. Reitano, L. Baccarin, B. Laverda, and D. Fedele
Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease
Diabetes Care, March 1, 2007; 30(3): 670 - 676.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. Chen, L. Lei, T. Jin, M. Nordberg, and G. F. Nordberg
Plasma Metallothionein Antibody, Urinary Cadmium, and Renal Dysfunction in a Chinese Type 2 Diabetic Population
Diabetes Care, December 1, 2006; 29(12): 2682 - 2687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.